Vulvar and Vaginal Cancer
1 clinical trials · Condition
◉ Watch Vulvar and Vaginal Cancer
| Record | Firm | Date |
|---|---|---|
| A Phase II, Single-arm, Multicenter, Prospective Study of Cardunolizumab in Recurrent or Metastatic Vulvar and Vaginal Cancer (NCT06292689) | Zhejiang Cancer Hospital | 2024-03-22 |
Track Vulvar and Vaginal Cancer automatically
Every clearance here is in the API, with alerts when new ones post.